The genomic epidemiology of multi-drug resistant invasive non-typhoidal Salmonella in selected sub-Saharan African countries.
Se Eun ParkDuy Thanh PhamGi Deok PakUrsula PanznerLigia Maria Cruz EspinozaVera von KalckreuthJustin ImOndari D MogeniHeidi Schütt-GerowittJohn A CrumpRobert F BreimanYaw Adu-SarkodieEllis Owusu-DaboRaphaël RakotozandrindrainyAbdramane Bassiahi SouraAbraham AseffaNagla GasmelseedArvinda SookaKaren H KeddyJürgen MayPeter AabyHolly M BiggsJulian T HertzJoel M MontgomeryLeonard CosmasBeatrice OlackBarry FieldsNimako SarpongTsiriniaina Jean Luco RazafindrabeTiana Mirana RaminosoaLeon Parfait KaboreEmmanuel SampoMekonnen TeferiBiruk YeshitelaMuna Ahmed El TayebRalf KrumkampDenise Myriam DekkerAnna JaegerAdama TallAmy GassamaAissatou NiangMorten Bjerregaard-AndersenSandra Valborg LøfbergJessica Fung DeerinJin Kyung ParkFrank KoningsMegan E CareySandra Van PuyveldeMohammad AliJohn ClemensGordon DouganStephen BakerFlorian MarksPublished in: BMJ global health (2021)
We identified the circulation of multiple MDR iNTS serovar STs in the sampled sub-Saharan African countries. Investment in the development and deployment of iNTS vaccines coupled with intensified antimicrobial resistance surveillance are essential to limit the impact of these pathogens in Africa.